People

Alicia B. Gilbert is an associate in King & Spalding’s Los Angeles office and a member of the firm’s Trial and Global Disputes practice. She focuses on complex commercial and securities litigation, regulatory enforcement matters, and government investigations.

Alicia represents corporations, financial institutions, directors, officers and other individuals in complex litigation involving securities laws and regulations, fraud, tortious conduct, breach of contract, corporate governance, the fiduciary obligations of corporate directors, and business disputes.  She also devotes significant time to pro bono matters.

Alicia graduated from the University of Pennsylvania Law School, where she was an Associate Editor of the Journal of Constitutional Law, and Spring Chair of the Moot Court Board.

ADMITTED TO PRACTICE ONLY IN NEW YORK. 

Full Bio

Credentials

J.D., University of Pennsylvania Law School

A.B., Brown University, honors, magna cum laude

California

New York

U.S. District Court for the Eastern District of New York

U.S. District Court for the Northern District of New York

U.S. District Court for the Southern District of New York

New York City Bar Association

Matters

Represented a global pharmaceutical company, as plaintiff, in an unfair competition action against a purported compounding pharmacy promoting and selling competing "compounded" drugs on a national basis. Obtained partial summary judgment as to liability on claims under the federal Lanham Act, California False Advertising Law, and California Unfair Competition Law. Allergan USA, Inc. v. Prescriber’s Choice, Inc. and Sincerus Florida, LLC, Case No. 8:17-cv-01550-DOC-JDE (C.D. Cal.).

Represented Darwin Deason, Xerox’s third-largest shareholder, in his attempt to nullify the acquisition of majority ownership in Xerox by Fujifilm. Deason v. Fujifilm Holdings Corp., et al., Index No. 650675/2018 (N.Y. Sup. Ct. Feb. 13, 2018).

Representing Citigroup Global Markets Inc. and Citigroup Global Markets Limited in an adversary proceeding filed in the Thornburg Mortgage bankruptcy cases in Maryland seeking to avoid over $2 billion in transfers and other obligations that Thornburg made or assumed prior to bankruptcy. Sher v. JPMorgan Chase Funding Inc., et al., Adv. No. 11-00340 (NVA) (Bankr. D. Md.).

See more
Icon close

Close

Matters

Represented a global pharmaceutical company, as plaintiff, in an unfair competition action against a purported compounding pharmacy promoting and selling competing "compounded" drugs on a national basis. Obtained partial summary judgment as to liability on claims under the federal Lanham Act, California False Advertising Law, and California Unfair Competition Law. Allergan USA, Inc. v. Prescriber’s Choice, Inc. and Sincerus Florida, LLC, Case No. 8:17-cv-01550-DOC-JDE (C.D. Cal.).

Represented Darwin Deason, Xerox’s third-largest shareholder, in his attempt to nullify the acquisition of majority ownership in Xerox by Fujifilm. Deason v. Fujifilm Holdings Corp., et al., Index No. 650675/2018 (N.Y. Sup. Ct. Feb. 13, 2018).

Representing Citigroup Global Markets Inc. and Citigroup Global Markets Limited in an adversary proceeding filed in the Thornburg Mortgage bankruptcy cases in Maryland seeking to avoid over $2 billion in transfers and other obligations that Thornburg made or assumed prior to bankruptcy. Sher v. JPMorgan Chase Funding Inc., et al., Adv. No. 11-00340 (NVA) (Bankr. D. Md.).

On trial team that represented PricewaterhouseCoopers LLP in a $3 billion malpractice lawsuit brought by the Plan Administrator of MF Global Holdings Ltd. MF Global Holdings Ltd., as Plan Administrator v. PricewaterhouseCoopers LLP, Civ. No. 14-CV-2197 (VM) (S.D.N.Y. Mar. 6, 2017).

Represented PwC in litigation involving Kentucky’s transition to a managed care Medicaid program. Kentucky Spirit Health Plan, Inc. v. Commonwealth of Kentucky, et al. (Franklin Cir. Ct., Ky. Nov. 9, 2016).

Representing a major broker-dealer in investigations by the SEC and FINRA related to the Customer Protection Rule (SEA Rule 15c3-3) and the Market Access Rule (SEA Rule 15c3-5).

Pro Bono

Representing federal death row inmate in post-conviction proceedings for a new trial based on multiple constitutional errors.

Matters

Represented a global pharmaceutical company, as plaintiff, in an unfair competition action against a purported compounding pharmacy promoting and selling competing "compounded" drugs on a national basis. Obtained partial summary judgment as to liability on claims under the federal Lanham Act, California False Advertising Law, and California Unfair Competition Law. Allergan USA, Inc. v. Prescriber’s Choice, Inc. and Sincerus Florida, LLC, Case No. 8:17-cv-01550-DOC-JDE (C.D. Cal.).

Represented Darwin Deason, Xerox’s third-largest shareholder, in his attempt to nullify the acquisition of majority ownership in Xerox by Fujifilm. Deason v. Fujifilm Holdings Corp., et al., Index No. 650675/2018 (N.Y. Sup. Ct. Feb. 13, 2018).

Representing Citigroup Global Markets Inc. and Citigroup Global Markets Limited in an adversary proceeding filed in the Thornburg Mortgage bankruptcy cases in Maryland seeking to avoid over $2 billion in transfers and other obligations that Thornburg made or assumed prior to bankruptcy. Sher v. JPMorgan Chase Funding Inc., et al., Adv. No. 11-00340 (NVA) (Bankr. D. Md.).

See more
Icon close

Close

Matters

Represented a global pharmaceutical company, as plaintiff, in an unfair competition action against a purported compounding pharmacy promoting and selling competing "compounded" drugs on a national basis. Obtained partial summary judgment as to liability on claims under the federal Lanham Act, California False Advertising Law, and California Unfair Competition Law. Allergan USA, Inc. v. Prescriber’s Choice, Inc. and Sincerus Florida, LLC, Case No. 8:17-cv-01550-DOC-JDE (C.D. Cal.).

Represented Darwin Deason, Xerox’s third-largest shareholder, in his attempt to nullify the acquisition of majority ownership in Xerox by Fujifilm. Deason v. Fujifilm Holdings Corp., et al., Index No. 650675/2018 (N.Y. Sup. Ct. Feb. 13, 2018).

Representing Citigroup Global Markets Inc. and Citigroup Global Markets Limited in an adversary proceeding filed in the Thornburg Mortgage bankruptcy cases in Maryland seeking to avoid over $2 billion in transfers and other obligations that Thornburg made or assumed prior to bankruptcy. Sher v. JPMorgan Chase Funding Inc., et al., Adv. No. 11-00340 (NVA) (Bankr. D. Md.).

On trial team that represented PricewaterhouseCoopers LLP in a $3 billion malpractice lawsuit brought by the Plan Administrator of MF Global Holdings Ltd. MF Global Holdings Ltd., as Plan Administrator v. PricewaterhouseCoopers LLP, Civ. No. 14-CV-2197 (VM) (S.D.N.Y. Mar. 6, 2017).

Represented PwC in litigation involving Kentucky’s transition to a managed care Medicaid program. Kentucky Spirit Health Plan, Inc. v. Commonwealth of Kentucky, et al. (Franklin Cir. Ct., Ky. Nov. 9, 2016).

Representing a major broker-dealer in investigations by the SEC and FINRA related to the Customer Protection Rule (SEA Rule 15c3-3) and the Market Access Rule (SEA Rule 15c3-5).

Pro Bono

Representing federal death row inmate in post-conviction proceedings for a new trial based on multiple constitutional errors.

Credentials

J.D., University of Pennsylvania Law School

A.B., Brown University, honors, magna cum laude

California

New York

U.S. District Court for the Eastern District of New York

U.S. District Court for the Northern District of New York

U.S. District Court for the Southern District of New York

New York City Bar Association